These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 2936148

  • 1. Altered metabolism of thromboxane A2 and prostacyclin in the pathogenesis of coronary vasospasm and thrombosis.
    Tada M, Kuzuya T.
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():481-4. PubMed ID: 2936148
    [Abstract] [Full Text] [Related]

  • 2. The role of coronary artery spasm in acute myocardial infarction.
    Oliva PB.
    Cardiovasc Clin; 1983; 14(1):45-58. PubMed ID: 6352027
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A study of platelet aggregation, thromboxane A2 and prostacyclin in central aortic and coronary sinus blood in ischemic heart disease.
    Narain VS, Bhargava B, Chandra N, Puri VK, Hasan M.
    Indian Heart J; 1994; 46(4):149-52. PubMed ID: 7875701
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Role of platelet and vascular eicosanoids in the pathophysiology of ischemic heart disease.
    Chierchia S, Patrono C.
    Fed Proc; 1987 Jan; 46(1):81-8. PubMed ID: 3542579
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Prostaglandins in coronary disease].
    Latour JG.
    Union Med Can; 1983 Mar; 112(3):260-7. PubMed ID: 6344382
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role of prostacyclin in the cardiovascular response to thromboxane A2.
    Cheng Y, Austin SC, Rocca B, Koller BH, Coffman TM, Grosser T, Lawson JA, FitzGerald GA.
    Science; 2002 Apr 19; 296(5567):539-41. PubMed ID: 11964481
    [Abstract] [Full Text] [Related]

  • 16. Cardiac release of prostacyclin and thromboxane A2 during coronary revascularization.
    Teoh KH, Fremes SE, Weisel RD, Christakis GT, Teasdale SJ, Madonik MM, Ivanov J, Mee AV, Wong PY.
    J Thorac Cardiovasc Surg; 1987 Jan 19; 93(1):120-6. PubMed ID: 3540456
    [Abstract] [Full Text] [Related]

  • 17. Drugs that modulate prostaglandins, prostacyclin, and thromboxane A2.
    Moncada S, Vane JR.
    Drug Ther; 1982 Jan 19; ():37-65. PubMed ID: 7049651
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis.
    Dogné JM, Hanson J, Pratico D.
    Trends Pharmacol Sci; 2005 Dec 19; 26(12):639-44. PubMed ID: 16243403
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.